Cholangiocarcinoma is a grave malignancy with 85–90% patients presenting to healthcare at advanced stage of disease. Best treatment for this condition is surgery and without surgery median survival is only 5–8 months. The most important prognostic factor is complete resection and absence of lymph node metastasis – both of which require early detection. In our study there were total 39(66%) hilar, 13(22%) distal and 7(12%) intrahepatic cholangiocarcinomas. 20 (34%) patients had distant metastasis at presentation itself. Only 3(5%) patients underwent curative resection and rest of the patients mainly underwent only palliative interventions. This is an important concern as the only chance for cure in cholangiocarcinoma is surgery and hence more studies are urgently required to focus on early detection and better treatment of this condition.